Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab (Annals of Hematology, (2020), 99, 7, (1493-1503), 10.1007/s00277-020-04133-z)

Ka Won Kang, Hyemi Moon, Byung Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim, Juneyoung Lee, Yong Park

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article inadvertently contained a typographical error in the Abstract section. In the Abstract, the p-value demonstrating the statistically significant difference between the transfusion-independence rate for the eculizumab-treated group and the eculizumab-untreated group should be p = 0.0078, and not p = 0.078. The correct p-value (p = 0.0078) has been mentioned in the main text of the manuscript, and the error is only in the Abstract section. The original article has been correction.

Original languageEnglish
Pages (from-to)3083
Number of pages1
JournalAnnals of Hematology
Volume100
Issue number12
DOIs
Publication statusPublished - 2021 Dec

Bibliographical note

Publisher Copyright:
© Springer-Verlag GmbH Germany, part of Springer Nature 2021.

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Correction to: Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab (Annals of Hematology, (2020), 99, 7, (1493-1503), 10.1007/s00277-020-04133-z)'. Together they form a unique fingerprint.

Cite this